logo

STE

STERIS·NYSE
--
--(--)
--
--(--)

STE fundamentals

STERIS (STE) released its earnings on Feb 4, 2026: revenue was 1.50B (YoY +6.87%), beat estimates; EPS was 2.53 (YoY +9.05%), missed estimates.
Revenue / YoY
1.50B
+6.87%
EPS / YoY
2.53
+9.05%
Report date
Feb 4, 2026
STE Earnings Call Summary for Q3,2026
  • Revenue Growth: 9% as-reported, 8% organic driven by price/volume.
  • Margin Challenges: Gross (-70bps), EBIT (-40bps) due to tariffs.
  • Segment Strength: AST services +9%, Life Sciences consumables +11%.
  • Tariff Impact: $55M annualized, $16M Q3.
  • Q4 Caution: Tough comps, but resilient capital spending.
  • Long-Term Outlook: Positive macro trends, disciplined M&A.
EPS
Revenue

Revenue & Expenses

STE has released its 2026 Q3 earnings report, with revenue of 1.50B, reflecting a YoY change of 9.16%, and net profit of 194.30M, showing a YoY change of 12.12%. The Sankey diagram below clearly presents STE's revenue sources and cost distribution.

Key Indicators

STERIS (STE) key financial stats and ratios, covering profitability, financial health, and leverage.
STERIS (STE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
STERIS (STE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
STERIS (STE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does STERIS (STE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track STERIS (STE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield